Organogenesis Holdings Inc (NASDAQ: ORGO) kicked off on Friday, down -3.83% from the previous trading day, before settling in for the closing price of $3.13. Over the past 52 weeks, ORGO has traded in a range of $2.16-$4.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 15.08% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -174.65%. With a float of $67.50 million, this company’s outstanding shares have now reached $132.58 million.
In an organization with 862 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 72.61%, operating margin of -2.39%, and the pretax margin is -3.26%.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 46.31%, while institutional ownership is 51.05%. The most recent insider transaction that took place on Dec 13 ’24, was worth 186,866. In this transaction President and CEO of this company sold 55,615 shares at a rate of $3.36, taking the stock ownership to the 3,044,779 shares. Before that another transaction happened on Dec 16 ’24, when Company’s President and CEO sold 5,585 for $3.49, making the entire transaction worth $19,492. This insider now owns 3,039,194 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -174.65% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Take a look at Organogenesis Holdings Inc’s (ORGO) current performance indicators. Last quarter, stock had a quick ratio of 2.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.83. Likewise, its price to free cash flow for the trailing twelve months is 97.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.06, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.63 million. That was better than the volume of 0.62 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 30.27%. Additionally, its Average True Range was 0.19.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 26.24%, which indicates a significant increase from 14.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.12% in the past 14 days, which was lower than the 69.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.46, while its 200-day Moving Average is $2.95. However, in the short run, Organogenesis Holdings Inc’s stock first resistance to watch stands at $3.07. Second resistance stands at $3.13. The third major resistance level sits at $3.20. If the price goes on to break the first support level at $2.95, it is likely to go to the next support level at $2.88. The third support level lies at $2.82 if the price breaches the second support level.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
The company with the Market Capitalisation of 378.43 million has total of 125,726K Shares Outstanding. Its annual sales at the moment are 433,140 K in contrast with the sum of 4,950 K annual income. Company’s last quarter sales were recorded 115,180 K and last quarter income was 12,330 K.
